Ultragenyx Pharmaceutical Inc. sell StockNews.com
Start price
29.11.23
/
50%
€35.60
Target price
29.11.24
-
Performance (%)
26.97%
End price
30.11.24
€45.20
Summary
This prediction ended on 30.11.24 with a price of €45.20. The prediction closed with a disappointing performance of 26.97%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.083% | 2.083% | -51.000% |
| iShares Core DAX® | -0.383% | 2.613% | 11.343% |
| iShares Nasdaq 100 | -0.411% | -2.005% | 5.353% |
| iShares Nikkei 225® | 1.838% | 9.391% | 33.529% |
| iShares S&P 500 | -0.712% | -0.476% | 2.508% |
Comments by StockNews_com for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten